---
type: "Bill"
title: "CONTROLLED SUBSTANCES-OPIOIDS"
description: "Amends the Illinois Controlled Substances Act. Provides that, notwithstanding any other provision of law, a prescription for a substance in Schedule II, III, IV, or V must be sent electronically, in accordance with provisions regarding the Prescription Monitoring Program. Effective immediately."
jurisdiction: "us/states/il"
legislature: "Illinois General Assembly"
session: "102nd"
identifier: "HB 3596"
citation: "Illinois HB 3596 (102nd)"
classification: ["bill"]
subjects: []
status: "enacted"
primary_sponsors: ["Dagmara Avelar", "Emil Jones, III"]
version_count: 4
action_count: 50
vote_count: 2
first_action: "2021-02-19"
last_action: "2021-08-20"
source: "openstates"
source_identifier: "ocd-bill/51268020-9926-4d99-b6db-234d6ca65498"
source_url: "https://ilga.gov/legislation/BillStatus.asp?DocNum=3596&GAID=16&DocTypeID=HB&LegId=132636&SessionID=110&GA=102"
source_hash: "c63dd66416db4acb3f41dea69d33a301b98657efb3324e776f7c5ff709adb1bf"
vintage: "2026-07-01"
source_snapshot: "https://data.openstates.org/daily/2026-07-01/public.pgdump"
retrieved_at: "2026-07-06"
confidence: "reported"
tags: ["legislation", "bill", "us-il"]
---

# Illinois HB 3596 (102nd) — CONTROLLED SUBSTANCES-OPIOIDS

Amends the Illinois Controlled Substances Act. Provides that, notwithstanding any other provision of law, a prescription for a substance in Schedule II, III, IV, or V must be sent electronically, in accordance with provisions regarding the Prescription Monitoring Program. Effective immediately.

## Version chain

The bill's text revisions, in order — the diff chain from filing to enrollment.

1. **Introduced** (filed) — [source](https://ilga.gov/legislation/102/HB/PDF/10200HB3596.pdf)
2. **Engrossed** (committee substitute) — [source](https://ilga.gov/legislation/102/HB/PDF/10200HB3596eng.pdf)
3. **House Amendment 001** (committee substitute) — [source](https://ilga.gov/legislation/102/HB/PDF/10200HB3596ham001.pdf)
4. **Enrolled** (enrolled) — [source](https://ilga.gov/legislation/102/HB/PDF/10200HB3596enr.pdf)

## Votes

- Third Reading — **59–0** (pass) · upper
- Third Reading — **111–0** (pass) · lower

## Sponsors

- Dagmara Avelar — primary (person)
- Emil Jones, III — primary (person)
- Aaron M. Ortiz — cosponsor (person)
- Angelica Guerrero-Cuellar — cosponsor (person)
- Anthony DeLuca — cosponsor (person)
- Barbara Hernandez — cosponsor (person)
- Christopher Belt — cosponsor (person)
- Delia C. Ramirez — cosponsor (person)
- Edgar Gonzalez, Jr. — cosponsor (person)
- Elizabeth Hernandez — cosponsor (person)
- Emanuel Chris Welch — cosponsor (person)
- Eva-Dina Delgado — cosponsor (person)
- Jaime M. Andrade, Jr. — cosponsor (person)
- Joyce Mason — cosponsor (person)
- Justin Slaughter — cosponsor (person)
- Kathleen Willis — cosponsor (person)
- La Shawn K. Ford — cosponsor (person)
- Mary E. Flowers — cosponsor (person)
- Stephanie A. Kifowit — cosponsor (person)

## Timeline

The legislative action history — every referral, reading, and vote.

- **2021-02-19** Filed with the Clerk by Rep. Dagmara Avelar `filing`
- **2021-02-22** First Reading `reading-1`
- **2021-02-22** Referred to Rules Committee `referral-committee`
- **2021-03-16** Assigned to Prescription Drug Affordability & Accessibility Committee `referral-committee`
- **2021-03-18** Added Co-Sponsor Rep. Aaron M. Ortiz
- **2021-03-18** Added Co-Sponsor Rep. Delia C. Ramirez
- **2021-03-18** Added Co-Sponsor Rep. Edgar Gonzalez, Jr.
- **2021-03-18** Added Co-Sponsor Rep. Jaime M. Andrade, Jr.
- **2021-03-18** Added Co-Sponsor Rep. Angelica Guerrero-Cuellar
- **2021-03-18** Added Co-Sponsor Rep. Eva-Dina Delgado
- **2021-03-18** Added Co-Sponsor Rep. Elizabeth Hernandez
- **2021-03-18** Added Co-Sponsor Rep. Barbara Hernandez
- **2021-03-25** Added Co-Sponsor Rep. Joyce Mason
- **2021-03-25** Do Pass / Short Debate Prescription Drug Affordability & Accessibility Committee; 018-000-000 `committee-passage`
- **2021-04-08** Placed on Calendar 2nd Reading - Short Debate
- **2021-04-13** Second Reading - Short Debate `reading-2`
- **2021-04-13** Placed on Calendar Order of 3rd Reading - Short Debate
- **2021-04-20** House Floor Amendment No. 1 Filed with Clerk by Rep. Dagmara Avelar `amendment-introduction`
- **2021-04-20** House Floor Amendment No. 1 Referred to Rules Committee `referral-committee`
- **2021-04-20** Added Co-Sponsor Rep. Emanuel Chris Welch
- **2021-04-20** Added Co-Sponsor Rep. Stephanie A. Kifowit
- **2021-04-20** Added Co-Sponsor Rep. Mary E. Flowers
- **2021-04-21** House Floor Amendment No. 1 Rules Refers to Prescription Drug Affordability & Accessibility Committee
- **2021-04-21** Added Co-Sponsor Rep. Justin Slaughter
- **2021-04-21** Added Co-Sponsor Rep. Kathleen Willis
- **2021-04-22** House Floor Amendment No. 1 Recommends Be Adopted Prescription Drug Affordability & Accessibility Committee; 017-002-000 `committee-passage-favorable`
- **2021-04-22** Added Co-Sponsor Rep. Anthony DeLuca
- **2021-04-23** Recalled to Second Reading - Short Debate `reading-2`
- **2021-04-23** House Floor Amendment No. 1 Adopted `amendment-passage`
- **2021-04-23** Placed on Calendar Order of 3rd Reading - Short Debate
- **2021-04-23** Third Reading - Short Debate - Passed 111-000-000 `passage, reading-3`
- **2021-04-23** Added Chief Co-Sponsor Rep. La Shawn K. Ford
- **2021-04-27** Arrive in Senate `introduction`
- **2021-04-27** Placed on Calendar Order of First Reading `reading-1`
- **2021-04-27** Chief Senate Sponsor Sen. Emil Jones, III
- **2021-04-27** First Reading `reading-1`
- **2021-04-27** Referred to Assignments `referral-committee`
- **2021-05-10** Assigned to Licensed Activities `referral-committee`
- **2021-05-19** Do Pass Licensed Activities; 007-000-000 `committee-passage`
- **2021-05-19** Placed on Calendar Order of 2nd Reading May 20, 2021
- **2021-05-20** Added as Alternate Chief Co-Sponsor Sen. Christopher Belt
- **2021-05-24** Second Reading `reading-2`
- **2021-05-24** Placed on Calendar Order of 3rd Reading May 25, 2021
- **2021-05-27** Placed on Calendar Order of 3rd Reading ** May 28, 2021
- **2021-05-29** Third Reading - Passed; 059-000-000 `passage, reading-3`
- **2021-05-29** Passed Both Houses
- **2021-06-25** Sent to the Governor `executive-receipt`
- **2021-08-20** Governor Approved `executive-signature`
- **2021-08-20** Effective Date January 1, 2023
- **2021-08-20** Public Act . . . . . . . . . 102-0490 `became-law`

## Source

OpenStates / OpenCivicData bulk snapshot [2026-07-01](https://data.openstates.org/daily/2026-07-01/public.pgdump); origin `ocd-bill/51268020-9926-4d99-b6db-234d6ca65498`. Confidence: reported (aggregated from official Illinois legislature records).